Compared with the PBS control, both types of NK cell therapy (NK + MSLN×CD16A and anti-MSLN CAR-like NK) significantly delayed tumor growth (Fig. 5d and Supplementary Fig. S2c). The gene discussed is MSLN; the disease is neoplasm.